Skovdal, Morten
Magoge-Mandizvidza, Phyllis
Dzamatira, Freedom
Maswera, Rufurwokuda
Nyamukapa, Constance
Thomas, Ranjeeta
Mugurungi, Owen
Gregson, Simon
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1161471)
National Institute of Mental Health (R01MH114562–01)
Medical Research Council (MR/R015600/1)
Article History
Received: 12 January 2022
Accepted: 12 April 2022
First Online: 23 April 2022
Declarations
:
: The study obtained ethical approvals from the Medical Research Council of Zimbabwe (REF: MRCZ/A/2243), the institutional review board of the Biomedical Research and Training Institute in Zimbabwe (REF: AP140/2017), and the Imperial College London Research Ethics Committee (REF: 17IC4160). All methods and procedures were performed in accordance with the relevant guidelines and regulations set forth by the aforementioned review boards. Written informed consent was obtained from all participants with the agreement that their identities would be kept confidential.
: Not applicable.
: SG declares shareholdings in pharmaceutical companies [GSK and Astra Zeneca]; all other authors have no conflicts of interest to declare.